CO48 A Non-Interventional Chart Review Study of Infliximab Precision-Guided Dosing Tool's Clinical Experience Program: Interim Analysis of Real-World Health Outcomes and Extrapolated Cost Savings
Abstract
Authors
A. Shim St.. Jacque S K. Young M. Ma P.. Aragon-Han